ABVC BioPharma ABVC 深 沪
已收盘 08-29 16:00:00 美东时间
2.83
-0.250
-8.12%
华盛通- 最 高3.13
- 今 开3.13
- 成交量 13.39万股
- 最 低 2.78
- 昨 收 3.08
- 总市值 4746.84万
- 52周最高 5.48
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.40
- 委 比 95.96%
- 总股本 1677.33万
- 历史最高 116.90
- 量 比 1.36
- 振 幅 11.36%
- 历史最低 0.40
- 每 手 1
- 风险率 0.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Abercrombie & Fitch and NFL Announce Official Fashion Partnership
Abercrombie & Fitch has become the NFL's first Official Fashion Partner in a multi-year agreement. The collaboration includes custom styling for NFL athletes, player-designed apparel, and activations at key NFL events. Abercrombie aims to redefine fan style by blending game-day and everyday fashion, creating connections with fans, especially women, through stylish, fandom-inspired products. The partnership also introduces the Abercrombie Style Co...
08-25 10:30
ABVC BioPharma Q2 EPS $(0.13) Down From $(0.09) YoY
ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.13) per share. This is a 44.44 percent decrease over losses of $(0.09) per share from the same period last year.
08-14 05:40
快讯 | ABVC生物制药公司申请混合货架，最高达1亿美元 - SEC文件
ABVC Biopharma Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
05-23 04:02
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biodesix (NASDAQ:BDSX) shares increased by 72.6% to $0.47 during Wedne...
05-22 01:06
'ABVC BioPharma Secures Japanese Patent For Its Natural MDD Treatment Candidate ABV-1504'
ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced
05-09 23:05
ABVC BioPharma Reports Strong Financial Growth
The latest announcement is out from ABVC BioPharma, Inc. ( ($ABVC) ). In 2024, ...
04-16 04:59
Abvc Biopharma's Leeds Chow Resigns As CFO; CEO Uttam Patil To Serve As Interim CFO
- SEC Filing
03-08 05:26
快讯 | ABVC生物制药公司 - 3月5日，李德斯·周辞去ABVC生物制药的首席财务官职务
ABVC Biopharma Inc - on March 5, Leeds Chow Resigns as CFO of ABVC Biopharma
03-08 05:20
ABVC BioPharma gets $200K in cash from OncoX BioPharma
ABVC BioPharma (NASDAQ:ABVC) said it has received a $200K cash payment from OncoX BioPharma as part of its strategic licensing agreement for certain oncology-related products. The payment is the first...
2024-12-11 20:16
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb
ABVC BioPharma (NASDAQ:ABVC) has secured an additional $50,000 in licensing fees from AiBtl BioPharma, it said on Tuesday, sending shares up in premarket trade. ABVC (ABVC) shares rose +4.89% premark...
2024-10-22 21:09
